Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) [Phase 1]
This document describes a Phase 1 dose-escalation trial of PT2385 in patients with advanced clear cell renal cell carcinoma (renal cell carc…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies [Phase 1]
Phase 1 study evaluating a triple combination of sitravatinib, nivolumab, and ipilimumab in advanced or metastatic clear-cell renal cell car…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer [Phase 1]
Phase 1 trial evaluating CBM588 capsules in combination with nivolumab and ipilimumab for advanced or metastatic renal cell carcinoma, inclu…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: 89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study [Phase 3]
Phase 3 ZIRCON trial evaluating the PET/CT imaging agent 89Zr-TLX250 for clear cell renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: 68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial update for 68Ga-NY104 PET/CT imaging in metastatic clear cell renal cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: 68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion [Phase 2]
Phase 2 clinical trial evaluating 68Ga-NY104 PET/CT for suspected metastasis/recurrence of clear cell renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses [Phase 2]
Phase 2 clinical trial evaluating 68Ga-NY104 PET/CT for detecting clear cell renal cell carcinoma in presurgical patients with renal masses.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab combined with axitinib as neoadjuvant therapy for non-metastatic locally advanced clear cell renal cell…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma [Phase 2]
Phase 2 trial investigating denosumab with pembrolizumab in clear cell renal cell carcinoma (metastatic).
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Clinical trial update for CB-839 in combination with nivolumab in melanoma, clear cell renal cell carcinoma, and non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating addition of X4P-001 to nivolumab in clear cell renal cell carcinoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 trial update evaluating a tailored immunotherapy approach with nivolumab in metastatic or advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial evaluating CB-839 with everolimus vs placebo with everolimus in clear cell renal cell carcinoma has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: A Clinical Study of 6MW3211 in Patients With Renal Cancer [Phase 2]
Phase 2 clinical trial update for 6MW3211 in advanced clear cell renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial update on nivolumab with stereotactic ablative radiation (SAbR) in metastatic clear cell renal cell carcinoma; the study is te…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma [Phase 2]
Phase 2 clinical trial investigating avelumab with IL-15 in clear-cell renal carcinoma has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) [Phase 2]
Phase 2 clinical trial update for INCMGA00012 in selected solid tumors, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer [Phase 2]
Phase 2 trial of pazopanib hydrochloride in stage IV renal cell carcinoma completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating pazopanib hydrochloride with or without ascorbic acid in metastatic or unresectable clear cell renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of CB-839 (telaglenastat) in combination with talazoparib in solid tumors was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer [Phase 1, Phase 2]
Investigator-initiated trial evaluating durvalumab and guadecitabine in advanced kidney cancer (Phase 1/2; status: active not recruiting).
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC [Phase 2]
Phase 2 study evaluating safety and efficacy of tislelizumab plus axitinib as neoadjuvant therapy for clear cell renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer [Phase 2]
Phase 2 clinical trial evaluating high-dose interleukin-2 combined with stereotactic ablative body radiotherapy in metastatic clear cell ren…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab plus axitinib as neoadjuvant therapy for locally advanced non-metastatic clear cell renal ce…
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating sintilimab in combination with axitinib for advanced renal cell carcinoma, including clear cell histology.